Fig. 3From: Cell death-related molecules and biomarkers for renal cell carcinoma targeted therapyProspective of combined therapy for RCC. Nonspecific immune therapy, targeted therapy, immune checkpoint therapy and novel new cell death-related molecules are shown, and their combination therapy is anticipatedBack to article page